News
Brand Revitalization | The 2023 China Brand Value Evaluation Report Released—Wanbangde Pharmaceutical Group Listed Again!
Date:
02 Jun,2023
Recently, the 2023 China Brand Value Evaluation Information Release Event and the China Brand Building Summit Forum were held in Zhejiang. During the event, Xinhua News Agency, the People's Government of Zhejiang Province, the China Brand Building Promotion Association, the China Asset Appraisal Association, and other organizations jointly released the "2023 China Brand Value Evaluation Information."
Wanbangde Pharmaceutical Group Co., Ltd. has been listed on the Autonomous Innovation Brands Ranking, boasting a brand strength of 713 and a brand value of 1.719 billion yuan! Reportedly, this is the pharmaceutical group's second year on the list, and its brand value has increased by 13.69% compared to last year.
The China Brand Building Promotion Association, in collaboration with relevant authoritative organizations, has been jointly hosting the public-interest "China Brand Value Evaluation Information Release" for a decade. This initiative aims to establish a brand value evaluation mechanism with Chinese characteristics, cultivate positive energy for Chinese brands, and play a vital role in promoting Chinese brands onto the global stage.
The release of China's brand value evaluation information adheres to international and national standards, upholding the principles of "scientific, fair, transparent, and widely recognized" practices—and is increasingly gaining societal attention and approval.
"Brand is quality, brand is profit, brand is competitiveness, and brand is vitality." Wanbangde Pharmaceutical Group is showcasing the strength of a national brand to the public—driven by its continuously growing brand value!
Related Recommendations
2021/02/07